Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$0.01
$0.02
$1.94
$581K0.672.58 million shs55,436 shs
Remedent, Inc. stock logo
REMI
Remedent
$0.01
$0.01
$0.01
$0.07
N/A-0.132 shs45 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.00%0.00%0.00%-89.13%-98.12%
Remedent, Inc. stock logo
REMI
Remedent
0.00%0.00%0.00%-10.20%-83.67%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$0.01
$0.02
$1.94
$581K0.672.58 million shs55,436 shs
Remedent, Inc. stock logo
REMI
Remedent
$0.01
$0.01
$0.01
$0.07
N/A-0.132 shs45 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.00%0.00%0.00%-89.13%-98.12%
Remedent, Inc. stock logo
REMI
Remedent
0.00%0.00%0.00%-10.20%-83.67%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BIOLASE, Inc. stock logo
BIOL
BIOLASE
3.00
Buy$0.40∞ Upside
Remedent, Inc. stock logo
REMI
Remedent
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$48.83M0.00N/AN/A($0.07) per share0.00
Remedent, Inc. stock logo
REMI
Remedent
$990KN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BIOLASE, Inc. stock logo
BIOL
BIOLASE
-$20.63M-$14.94N/AN/AN/A-41.65%-1,782.73%-55.31%N/A
Remedent, Inc. stock logo
REMI
Remedent
-$270K-$0.01N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/AN/AN/AN/AN/A
Remedent, Inc. stock logo
REMI
Remedent
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/A
0.71
0.36
Remedent, Inc. stock logo
REMI
Remedent
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
BIOLASE, Inc. stock logo
BIOL
BIOLASE
8.79%
Remedent, Inc. stock logo
REMI
Remedent
N/A

Insider Ownership

CompanyInsider Ownership
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.27%
Remedent, Inc. stock logo
REMI
Remedent
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
BIOLASE, Inc. stock logo
BIOL
BIOLASE
16033.41 million33.32 millionNot Optionable
Remedent, Inc. stock logo
REMI
Remedent
4N/AN/ANot Optionable

Recent News About These Companies

Rémi Laurent Biography & Movies
Rémi Laurent Biography & Movies
REMYY Rémy Cointreau SA
Remi Lambert
Peterson Remy
Remi Monaghan
remy ma and papoose
Rémi Bonnet Breaks Longtime Pikes Peak Ascent Record
Home and Away spoiler: Remi keeps quiet about the kiss

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIOLASE stock logo

BIOLASE NASDAQ:BIOL

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Remedent stock logo

Remedent OTCMKTS:REMI

$0.0090 0.00 (0.00%)
As of 09/12/2025

Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.